Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic Acid for Prevention of Anti-Tuberculosis Drug-Induced Liver Injury
TCTR20251016001Phase 2Not yet recruiting
- Sponsor
- Khon Kaen University
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ursodeoxycholic acid in Tuberculosis (TB), Drug-induced hepatitis (DILI), sponsored by Khon Kaen University. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
ursodeoxycholic acid
03
Conditions
Tuberculosis (TB)Drug-induced hepatitis (DILI)
Beyond the preview
Go deeper on TCTR20251016001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251016001.